A Case of Azathioprine Induced Severe Myelosuppression and Alopecia Totalis in IgA Nephropathy [PDF]
Childhood Kidney Diseases, 2017 Azathioprine is commonly used as immunosuppressive therapy for various inflammatory diseases including chronic glomerulonephritis. Myelosuppression is a common side effect of azathioprine, resulting in the need for dose reduction.
Jae Choon Kim +6 more
doaj +3 more sources
Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis [PDF]
Acta Dermato-Venereologica, 2023 Alopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the ...
Nicolae Done +6 more
doaj +2 more sources
Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecial Totalis and Alopecia Universalis: A Randomized, Double-Blind, Placebo-Controlled Trial [PDF]
Siriraj Medical Journal, 2017 Background: Alopecia totalis (AT) and alopecia universalis (AU) have a high rate of recurrence and are very difficult to treat. To date, no consensus has been reach among clinicians regarding the best way to treat these conditions.
Rattapon Thuangtong +5 more
doaj +5 more sources
Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Diagnosis and severity assessment [PDF]
Przegląd Dermatologiczny, 2023 The existence of two types of alopecia areata is suggested (probably genetically different): early-onset, with more severe symptoms, longer disease duration, higher tendency to relapse, often with a positive family history, and late-onset, in which the ...
Adriana Rakowska +8 more
doaj +2 more sources
Platelet-rich plasma efficacy in alopecia areata patients with normal and elevated levels of antibodies against thyroglobulin and thyroid peroxidase [PDF]
Folia MedicaAim: To evaluate and compare the efficacy of platelet-rich plasma (PRP) therapy in alopecia areata (AA) patients with normal and with elevated levels of anti-thyroglobulin antibodies and/or anti-thyroid peroxidase antibodies.
Tsvetana I. Abadjieva +3 more
doaj +5 more sources
Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study [PDF]
Acta Dermato-Venereologica, 2018 Treatment of alopecia totalis and alopecia universalis is often challenging and unsatisfactory. Recently, Janus kinase inhibitor has shown promising results.
Jung-Won Shin +6 more
doaj +2 more sources
Adult onset loose anagen hair syndrome with alopecia totalis [PDF]
Al Ameen Journal of Medical Sciences, 2008 A young adult male patient presented with diffuse hair loss of two years duration. Clinical features and investigations were suggestive of loose anagen hair syndrome. He developed alopecia totalis during follow-up.
Aparna Palit
doaj +2 more sources
Progress in immune pathogenesis and targeted therapy of alopecia areata [PDF]
Pifu-xingbing zhenliaoxue zazhi, 2023 Alopecia areata is a common clinical non-cicatricial alopecia. Alopecia totalis and generalized alopecia may occur in severe cases. The pathogenesis of alopecia areata is complex, and the treatment is faced with many difficulties.
Jiali WANG +3 more
doaj +2 more sources
Hepatitis C Treatment and Alopecia Totalis [PDF]
Journal of Investigative Dermatology Symposium Proceedings, 2013 Peg-interferon alpha-2a and 2b and ribavirin have become the mainstays of chronic hepatitis C treatment. Although various cutaneous side effects have been reported, alopecia areata in its various forms have rare reports and has not been well categorized.
Goh, Carolyn
openaire +4 more sources
Successful treatment of alopecia totalis with ruxolitinib in a preadolescent patient [PDF]
JAAD Case Reports, 2020 Matthew Vesely
exaly +2 more sources